2008Zhongguo linchuang baojian zazhiRequires access

The analysis on intravenous thrombolytic therapy in the elderly with acute myocardial infarction

Wang Li-hua

Open publisher page 0 citations

Abstract

Objective To investigate the clinical efficacy of intravenous thrombolytic therapy for the elderly(≥60 years) with acute myocardial infarction(AMI).Methods 59 aged cases with AMI were divided into two groups,in which 21 cases of intravenous urokinase(UK) thrombolysis were divided into thrombolysis group(group A),and 38 cases of non-thrombolysis in synchronization into non-thrombolysis group(group B) with the same therapy as thrombolysis group except UKResults Coronary recanalization rate and mortality rate in group A were 66.7% and 4.8% respectively,which were higher those in group B(P0.05).Serious arrhythmias rates in group A and group B were 28.5%(6/21) and 52.6%(20/38),which were significantly different(P0.05).Conclusion Urokinase intravenous thrombolytisis for the elderly patients with acute myocardial infarction can increase recanalization rate,reduce the mortality rate and improve the prognosis.

About this research paper

What this paper is about

Objective To investigate the clinical efficacy of intravenous thrombolytic therapy for the elderly(≥60 years) with acute myocardial infarction(AMI).Methods 59 aged cases with AMI were divided into two groups,in which 21 cases of intravenous urokinase(UK) thrombolysis were divided into thrombolysis group(group A),and 38 cases of non-thrombolysis in synchronization into non-thrombolysis group(group B) with the same therapy as thrombolysis group except UKResults Coronary recanalization rate and mortality rate in group A were 66.7% and 4.8% respectively,which were higher those in group B(P0.05).Serious arrhythmias rates in group A and group B were 28.5%(6/21) and 52.6%(20/38),which were significantly different(P0.05).Conclusion Urokinase intravenous thrombolytisis for the elderly patients with acute myocardial infarction can increase recanalization rate,reduce the mortality rate and improve the prognosis.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To investigate the clinical efficacy of intravenous thrombolytic therapy for the elderly(≥60 years) with acute myocardial infarction(AMI).Methods 59 aged cases with AMI were divided into two groups,in which 21 cases of intravenous urokinase(UK) thrombolysis were divided into thrombolysis group(group A),and 38 cases of non-thrombolysis in synchronization into non-thrombolysis group(group B) with the same therapy as thrombolysis group except UKResults Coronary recanalization rate and mortality rate in group A were 66.7% and 4.8% respectively,which were higher those in group B(P0.05).Serious arrhythmias rates in group A and group B were 28.5%(6/21) and 52.6%(20/38),which were significantly different(P0.05).Conclusion Urokinase intravenous thrombolytisis for the elderly patients with acute myocardial infarction can increase recanalization rate,reduce the mortality rate and improve the prognosis.

Key concepts: Medicine, Urokinase, Thrombolysis, Myocardial infarction, Group B, Mortality rate, Internal medicine, Cardiology

Related papers

Back to paper searchBrowse research topicsOriginal source
The analysis on intravenous thrombolytic therapy in the elderly with acute myocardial infarction — Research Paper | ScholarLens